Azelaic acid

Pre-clinicalCompleted
0 watching 0 views this week๐Ÿ’ค Quiet
20
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Rosacea

Conditions

Rosacea

Trial Timeline

Jul 1, 2010 โ†’ Feb 1, 2011

About Azelaic acid

Azelaic acid is a pre-clinical stage product being developed by Bayer for Rosacea. The current trial status is completed. This product is registered under clinical trial identifier NCT01631656. Target conditions include Rosacea.

Hype Score Breakdown

Clinical
5
Activity
2
Company
7
Novelty
2
Community
1

Clinical Trials (2)

NCT IDPhaseStatus
NCT01631656Pre-clinicalCompleted
NCT01038869ApprovedCompleted